Abstract:Next Generation Sequencing (NGS) is an important technology to identify genetic changes involved in lymphoid malignancies. Genome-level understanding of these changes can aid in diagnosis, prognosis, and therapy selection. Cancer biopsies are often preserved by formalin-fixed, paraffin-embedding (FFPE) procedures which provide long-term preservation but introduce damage to nucleic acids that are present in tissue including double strand breaks, nicks, and oxidation. The gold standard for Lymphoma diagnosis is surgical removal of the lymph node making FFPE the preferred sample format for analysis. To address the need for high quality reference materials for tumor profiling assays for these patients, we developed two multiplexed, biosynthetic reference materials: the Seraseq® FFPE Lymphoma DNA Reference Material and the Seraseq® Lymphoma DNA Mutation Mix. Both contain 26 plasmids containing important SNVs, INDELs, and gene fusions in lymphoid disease. For the FFPE format, plasmids were pooled at equal concentrations and introduced into the GM24385 reference human cell line. Engineered cells were diluted to achieve desired allele frequencies (AFs) as determined by digital PCR (dPCR). The cells were processed with a proprietary FFPE protocol that mimics damage in patient samples. The QIAamp DNA FFPE Tissue Kit and the Maxwell RSC DNA FFPE Kit were used for DNA isolation. DNA was quantified by the Qubit dsDNA HS Assay and quality assessed by the Agilent TapeStation. AFs were determined by dPCR for QIAamp-extracted DNA and a custom ArcherDX VariantPlex NGS panel for DNA extracted by both kits. DNA yield was similar, 193±44 ng (QIAamp) and 124±11 ng (Maxwell); however, a higher DNA integrity number was observed with the QIAamp kit (6.1 vs 2.7). The average % AF by dPCR was 9.6±1.8 (QIAamp) (target ≥5%). The average % AF by NGS was 7.6±2.8 (QIAamp) and 3.3±1.1 (Maxwell). For the DNA mix format, the same plasmids were pooled and blended with total purified genomic DNA from GM24385 cells. The average % AF was 8.4±0.6 by dPCR (target 5-10%) and 8.2±1.6 for the ArcherDX VariantPlex NGS panel. Overall, there was good concordance between AFs measured by dPCR and NGS for the DNA and FFPE formats. We noted that overall sample performance may be impacted by the FFPE DNA extraction method used. In conclusion, these reference materials allow for monitoring of a broad range of somatic mutations and gene fusions which can aid testing laboratories in accurately detecting and quantifying various genetic events in Lymphoid patient samples. The FFPE format can serve as an extraction control in assay development, while the DNA mix format allows laboratories to go directly into NGS library preparation and dPCR. A complementary circulating tumor DNA (ctDNA) version of these reference materials would aid laboratories in detecting minimal residual disease in patient blood resulting in less invasive lymphoid testing and therapeutic response monitoring. Citation Format: Tonya N. Watkins, Benedicta Forson, Dana Ruminski Lowe, Yves Konigshofer, Catherine Huang, Omoshile Clement, Bharathi Anekella. Comprehensive NGS-based reference materials for variant detection in lymphoid cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl) nr 756.

Somatic Mutation Screening Using Archival Formalin-Fixed, Paraffin-Embedded Tissues by Fluidigm Multiplex PCR and Illumina Sequencing

Mutation screening using formalin-fixed paraffin-embedded tissues: a stratified approach according to DNA quality

Identification Of High-Confidence Somatic Mutations In Whole Genome Sequence Of Formalin-Fixed Breast Cancer Specimens

Flow Cytometric Sorting Coupled with Exon Capture Sequencing Identifies Somatic Mutations in Archival Lymphoma Tissues

A superior strategy for single-cell mutational screening via multiplex-targeted QPCR using the BioMark HD microfluidic platform.

Somatic Point Mutation Calling in Low Cellularity Tumors

Accurate Detection of Multiple Tumor Mutations in Formalin-Fixed Paraffin-Embedded Tissues by Coupling Sequence Artifacts Elimination and Mutation Enrichment with MeltArray.

Validation of Two New Methods for Mutation Detection in Sporadic Ovarian Cancer

Single nucleus DNA sequencing of flow sorted archived frozen and formalin fixed paraffin embedded solid tumors

Analyzing somatic mutations by single-cell whole-genome sequencing

Performance Study of an Amplification-Based NGS Test on Clinical FFPE Specimens in China's First Multi-Center Study.

Large-scale analysis of whole genome sequencing data from formalin-fixed paraffin-embedded cancer specimens demonstrates preservation of clinical utility

Genome-scale mutational signature analysis in fixed archived tissues

Systematic review and feasibility study on pre-analytical factors and genomic analyses on archival formalin-fixed paraffin-embedded breast cancer tissue

Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS

Comparison of Accuracy of Whole-Exome Sequencing with Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tissue Samples

Transcriptome Analysis of Archived Tumor Tissues by Visium, GeoMx DSP, and Chromium Methods Reveals Inter- and Intra-Patient Heterogeneity

Abstract 756: Comprehensive NGS-based reference materials for variant detection in lymphoid cancer

Abstract 151: an Improved Computational Pipeline for Tumor Somatic Alterations Detection

Formalin-Fixed and Paraffin-Embedded Samples for Next Generation Sequencing: Problems and Solutions

Abstract 338: Unraveling layers of proteogenomic complexity in cancer through multiomic exploration of archived FFPE tissue